Intermediate and process for preparing of betaanomer enriched 21deoxy, 21 ,21-difluoro-D-ribofuranosyl nucleosides

Details for Australian Patent Application No. 2005328519 (hide)

Owner Fresenius Kabi Oncology Limited

Inventors Bhatt, Deependra; Maikap, Golak Chandra; Panda, Bijan Kumar

Agent Davies Collison Cave

Pub. Number AU-B-2005328519

PCT Pub. Number WO2006/092808

Priority 472/DEL/2005 04.03.05 IN

Filing date 23 September 2005

Wipo publication date 8 September 2006

Acceptance publication date 1 March 2012

International Classifications

C07H 13/08 (2006.01) Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids

C07H 19/073 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/092808 Priority application(s): WO2006/092808

17 September 2009 Alteration of Name

  The name of the applicant has been altered to Fresenius Kabi Oncology Limited 2006

1 March 2012 Application Accepted

  Published as AU-B-2005328519

28 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005328535-Intraparietal reinforcing device for biological cardiac prosthesis and reinforced biological heart valve prosthesis

2005328475-External plaster containing flurbiprofen